Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cardiomyopathies

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrieu, N; de Vaumas, C; Delpy, E; Hatem, SN; Henaff, M; Jaffrézou, JP; Laurent, G; Levade, T; Mercadier, JJ; Rücker-Martin, C1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Cardiomyopathies

ArticleYear
Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes.
    Cardiovascular research, 1999, Aug-01, Volume: 43, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiomyopathies; Cells, Cultured; Ceramides; DNA Fragmentation; Doxorubicin; Enzyme Inhibitors; In Situ Nick-End Labeling; Male; Morpholines; Myocardium; Rats; Rats, Wistar; Time Factors

1999